ArticleBlood2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia.
Meng-Xiao Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleBlood2024
Meng-Xiao Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.